U.S. In-Vitro Fertilization Services Market Expected to Reach $13,944.38 Million by 2032

According to a new report published by Allied Market Research, titled, “U.S. In-Vitro Fertilization Services Market: Opportunity Analysis and Industry Forecast, 2025–2032," The U.S. In-vitro fertilization services market was valued at $5,910.98 million in 2024 and is projected to reach $13,944.38 million by 2035, registering a CAGR of 11.3% from 2025 to 2032.

In-vitro fertilization (IVF) is an advanced assisted reproductive technology used to help individuals and couples conceive a child when natural conception is not possible or has proven difficult. The procedure involves retrieving mature eggs from a woman’s ovaries and fertilizing them with sperm in a controlled laboratory environment. Once fertilization occurs, the resulting embryos are cultured for a few days and then one or more are transferred into the woman's uterus, where implantation and pregnancy may occur. IVF is often used in cases of blocked or damaged fallopian tubes, male infertility, ovulation disorders, unexplained infertility, or when other fertility treatments have failed. The process may also involve the use of donor eggs, sperm, or embryos, and in some cases, gestational surrogacy.

The major factors driving the growth of the U.S. In-vitro fertilization services U.S. In-vitro fertilization services market are increasing infertility issues, surge in awareness and acceptance of IVF, expanding insurance coverage and favorable reimbursement policies, and rise in number of fertility clinics and service providers. The increasing awareness and acceptance of In-vitro fertilization (IVF) procedures have emerged as significant factors driving the growth of the IVF market in the U.S. Over the past decade, widespread educational campaigns, improved access to reproductive health information, and rise in awareness about infertility treatments have significantly contributed to growing adoption of IVF services. For instance, National Infertility Awareness Week (NIAW) is an annual event held in the U.S., typically during the last week of April, to raise awareness about infertility and its impact on individuals and couples.

Couples and individuals facing fertility challenges are now more likely to seek medical assistance without hesitation, encouraged by the normalization of IVF through media, online platforms, and testimonials. Additionally, the growing visibility of IVF success stories, through digitization has helped to reduce societal stigma and promote acceptance. Fertility clinics and healthcare organizations have also played a key role by actively engaging in patient education and outreach, emphasizing IVF’s safety, effectiveness, and evolving technologies.

The growing number of IVF procedures is a major factor driving the expansion of the IVF services market in the U.S. According to a 2025 article by the American Society of Reproductive Medicine, in 2023, around 95,860 babies were born through IVF. This increase is largely attributed to rise in infertility rates, driven by lifestyle factors such as stress, obesity, delayed parenthood, and increased prevalence of medical conditions like polycystic ovary syndrome (PCOS) and endometriosis. Additionally, growing societal acceptance of assisted reproductive technologies (ART) has encouraged more couples to seek IVF treatment. The availability of advanced fertility clinics, skilled professionals, and cutting-edge technologies has further made IVF more accessible and effective, leading to a higher success rate and boosting confidence among prospective patients. Moreover, the increasing utilization of IVF among single parents and same-sex couples, along with medical tourism within the country for fertility treatments, has significantly contributed to the rising number of IVF procedures.

The rise in the number of fertility clinics and service providers across the U.S. is a significant factor driving the growth of the IVF services market. As demand for assisted reproductive technologies increases due to factors such as delayed parenthood, rise in infertility rates, and greater social acceptance of IVF, there has been a corresponding expansion in the number of specialized fertility centers offering comprehensive reproductive care. These clinics are equipped with advanced technologies and staffed by skilled professionals, making IVF services more accessible and effective. The growing presence of both independent clinics and hospital-based fertility centers has not only increased the availability of services but has also fostered competitive pricing and innovation in treatment options. Moreover, many clinics are now offering personalized treatment plans, financing options, and additional services such as egg freezing and genetic screening, further enhancing patient engagement and satisfaction. Some of leading IVF centers are Boston IVF, LLC, Colorado Center for Reproductive Medicine, Pacific Fertility Center, Houston Fertility Institute and Cleveland Clinic Fertility Center.

The U.S. In-Vitro fertilization services market is segmented on the basis of gender, procedure, cycle type, end user, and offering. On the basis of gender, the market is divided into male infertility, female Infertility, and others. On the basis of procedure, the market is divided into ICSI IVF, Non ICSI IVF, and IUI. On the basis of cycle, the market is divided into IVF cycle and IUI cycle. IVF cycle is further divided into fresh IVF cycle, thawed IVF cycles, and donor egg IVF cycles. On the basis of end user, the market is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. On the basis of offering, the U.S. In-vitro fertilization services market is divided into IVF drugs, IVF media and reagents, and IVF & IUI services.

On the basis of gender, the female segment was the major revenue contributor in 2024 and is expected to witness a significant CAGR during the forecast period. This is attributed to range of medical, social, and lifestyle factors. Increasing maternal age due to delayed family planning for career or educational reasons has significantly contributed to growing demand for IVF treatments.

On the basis of procedure, the ICSI IVF segment was the major revenue contributor in 2024 and is expected to witness a significant CAGR during the forecast period. This is attributed to infertility rates, particularly male factor infertility, which accounts for a significant proportion of cases requiring ICSI. This technique is being increasingly opted, as it offers higher fertilization success in cases where sperm quality, motility, or count is low. 

On the basis of cycle type, the IVF segment was the major revenue contributor in 2024 and is expected to witness a significant CAGR during the forecast period. This is attributed to higher success rates, especially in cases of advanced maternal age, unexplained infertility, or male infertility. IVF provides greater control over fertilization and embryo selection, improving the chances of pregnancy compared to IUI, which relies on natural fertilization within the body

On the basis of end user, the fertility clinics segment was the major revenue contributor in 2024 and is expected to witness a significant CAGR during the forecast period. Fertility centers are dedicated exclusively to reproductive health and are equipped with state-of-the-art technologies such as time-lapse embryo monitoring, preimplantation genetic testing (PGT), and vitrification techniques, which significantly enhance treatment success rates. These centers provide personalized treatment plans, advanced diagnostic tools, and access to cutting-edge technologies enhancing treatment effectiveness.

On the basis of offering, the IVF and IUI services segment was the major revenue contributor in 2024. This is attributed to rising prevalence of infertility, driven by factors such as obesity, diabetes, thyroid dysfunction, environmental pollutants, sexually transmitted infections, and age-related fertility decline, which increases the demand for these services.

Key findings of the study 

• By gender, the female segment was the highest contributor to the U.S. In-vitro fertilization services market in 2024 and is expected to register the highest CAGR during the forecast period.
• By procedure, the ICSI IVF was the highest contributor to the market in 2024 and is expected to register the highest CAGR during the forecast period. 
• By cycle type, the IVF cycle segment was the highest contributor to the U.S. In-vitro fertilization services market in 2024 and is expected to register the highest CAGR during the forecast period.
• By end user, the fertility centers segment was the highest contributor to the market in 2024 and is expected to register the highest CAGR during the forecast period.
• By offering, the IVF and IUI services segment was the highest contributor to the U.S. In-vitro fertilization services market in 2024 and is expected to register the highest CAGR during the forecast period.